Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 309261, 14 pages
http://dx.doi.org/10.1155/2015/309261
Review Article

Neuropharmacological Potential of Gastrodia elata Blume and Its Components

1College of Veterinary Medicine and Animal Medical Institute, Chonnam National University, Gwangju 500-757, Republic of Korea
2Cheongju Hamsoa Oriental Clinic, Cheongju 361-814, Republic of Korea
3College of Veterinary Medicine, Jeju National University, Jeju 690-756, Republic of Korea

Received 21 April 2015; Revised 6 September 2015; Accepted 15 September 2015

Academic Editor: Thierry Hennebelle

Copyright © 2015 Jung-Hee Jang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Knopman, “Current treatment of mild cognitive impairment and Alzheimer's disease,” Current Neurology and Neuroscience Reports, vol. 6, no. 5, pp. 365–371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Yamada and T. Nabeshima, “Animal models of Alzheimer's disease and evaluation of anti-dementia drugs,” Pharmacology & Therapeutics, vol. 88, no. 2, pp. 93–113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. H. V. Schapira, E. Bezard, J. Brotchie et al., “Novel pharmacological targets for the treatment of Parkinson's disease,” Nature Reviews Drug Discovery, vol. 5, no. 10, pp. 845–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Davis, K. Lees, and G. Donnan, “Treating the acute stroke patient as an emergency: current practices and future opportunities,” International Journal of Clinical Practice, vol. 60, no. 4, pp. 399–407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Shi, X. Tang, X. Dang et al., “Investigating herb-herb interactions: the potential attenuated toxicity mechanism of the combined use of Glycyrrhizae radix et rhizoma (Gancao) and Sophorae flavescentis radix (Kushen),” Journal of Ethnopharmacology, vol. 165, pp. 243–250, 2015. View at Publisher · View at Google Scholar
  6. S. C. C. Chik, T. C. T. Or, D. Luo, C. L. H. Yang, and A. S. Y. Lau, “Pharmacological effects of active compounds on neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction,” The Scientific World Journal, vol. 2013, Article ID 896873, 22 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Xiong, X. Yang, Y. Liu, Y. Zhang, P. Wang, and J. Wang, “Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science,” Hypertension Research, vol. 36, no. 7, pp. 570–579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Y. Jiang, X. Z. Wang, and S. S. Luo, “Effect of banxia baizhu tianma decoction on the left ventricular hypertrophy of hypertrophied myocardium in spontaneously hypertensive rat,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, vol. 30, no. 10, pp. 1061–1066, 2010. View at Google Scholar
  9. H.-X. Tang, A.-Y. Li, J.-J. Li, G.-S. Hou, and F. Zhang, “Effect of Ningdong Granule on the levels of IL-12 and TNF-alpha in children patients with Tourette's syndrome,” Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi, vol. 34, no. 4, pp. 435–438, 2014. View at Google Scholar · View at Scopus
  10. P.-J. Chen and L.-Y. Sheen, “Gastrodiae rhizoma (tiān má): a review of biological activity and antidepressant mechanisms,” Journal of Traditional and Complementary Medicine, vol. 1, no. 1, pp. 31–40, 2011. View at Google Scholar · View at Scopus
  11. J. Liu and A. Mori, “Antioxidant and free radical scavenging activities of Gastrodia elata Bl. and Uncaria rhynchophylla (Miq.) Jacks,” Neuropharmacology, vol. 31, no. 12, pp. 1287–1298, 1992. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Zhao, X.-J. Gong, X. Zhou, and Z.-J. Kang, “Relative bioavailability of gastrodin and parishin from extract and powder of Gastrodiae rhizoma in rat,” Journal of Pharmaceutical and Biomedical Analysis, vol. 100, pp. 309–315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L.-C. Lin, Y.-F. Chen, W.-C. Lee, Y.-T. Wu, and T.-H. Tsai, “Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC-MS/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 48, no. 3, pp. 909–917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-Y. Jung, S.-I. Suh, H. Lee et al., “Protective effects of several components of Gastrodia elata on lipid peroxidation in gerbil brain homogenates,” Phytotherapy Research, vol. 21, no. 10, pp. 960–964, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. X.-H. Duan, Z.-L. Li, D.-S. Yang, F.-L. Zhang, Q. Lin, and R. Dai, “Study on the chemical constituents of Gastrodia elata,” Zhong Yao Cai, vol. 36, no. 10, pp. 1608–1611, 2013. View at Google Scholar · View at Scopus
  16. Z. Li, Y. Wang, H. Ouyang et al., “A novel dereplication strategy for the identification of two new trace compounds in the extract of Gastrodia elata using UHPLC/Q-TOF-MS/MS,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 988, pp. 45–52, 2015. View at Publisher · View at Google Scholar
  17. C. Tang, L. Wang, J. Li, X. Liu, M. Cheng, and H. Xiao, “Analysis of the metabolic profile of parishin by ultra-performance liquid chromatography/quadrupole-time of flight mass spectrometry,” Biomedical Chromatography, 2015. View at Publisher · View at Google Scholar
  18. B.-W. Kim, S. Koppula, J.-W. Kim et al., “Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 549–557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-B. Li and F. Chen, “Preparative isolation and purification of gastrodin from the Chinese medicinal plant Gastrodia elata by high-speed counter-current chromatography,” Journal of Chromatography A, vol. 1052, no. 1-2, pp. 229–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. M. Ojemann, W. L. Nelson, D. S. Shin, A. O. Rowe, and R. A. Buchanan, “Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions,” Epilepsy & Behavior, vol. 8, no. 2, pp. 376–383, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Y. Lee, Y. W. Jang, H. S. Kang, H. Moon, S. S. Sim, and C. J. Kim, “Anti-inflammatory action of phenolic compounds from Gastrodia elata root,” Archives of Pharmacal Research, vol. 29, no. 10, pp. 849–858, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. B. Young and G. E. Fagg, “Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches,” Trends in Pharmacological Sciences, vol. 11, no. 3, pp. 126–133, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-L. Hsieh, N.-Y. Tang, S.-Y. Chiang, C.-T. Hsieh, and L. Jaung-Geng, “Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (MIQ) Jack and Gastrodia elata Bl., in kainic acid-treated rats,” Life Sciences, vol. 65, no. 20, pp. 2071–2082, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-L. Hsieh, S.-Y. Chiang, K.-S. Cheng et al., “Anticonvulsive and free radical scavenging activities of Gastrodia elata Bl. in kainic acid-treated rats,” The American Journal of Chinese Medicine, vol. 29, no. 2, pp. 331–341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. H.-J. Kim, K.-D. Moon, S.-Y. Oh, S.-P. Kim, and S.-R. Lee, “Ether fraction of methanol extracts of Gastrodia elata, a traditional medicinal herb, protects against kainic acid-induced neuronal damage in the mouse hippocampus,” Neuroscience Letters, vol. 314, no. 1-2, pp. 65–68, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-L. Hsieh, J.-J. Lin, S.-Y. Chiang et al., “Gastrodia elata modulated activator protein 1 via c-Jun N-terminal kinase signaling pathway in kainic acid-induced epilepsy in rats,” Journal of Ethnopharmacology, vol. 109, no. 2, pp. 241–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Ushijima, T. Kobayashi, M. Suetsugi, K. Watanabe, M. Yamada, and K. Yamaguchi, “Cocaine: evidence for NMDA-, beta-carboline- and dopaminergic-mediated seizures in mice,” Brain Research, vol. 797, no. 2, pp. 347–350, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-H. Ye and J. Ren, “Cocaine inhibition of GABAA current: role of dephosphorylation,” Critical Reviews in Neurobiology, vol. 18, no. 1-2, pp. 85–94, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. E.-J. Shin, J.-H. Bach, T.-T. L. Nguyen et al., “Gastrodia elata Bl attenuates cocaine-induced conditioned place preference and convulsion, but not behavioral sensitization in mice: importance of GABAA receptors,” Current Neuropharmacology, vol. 9, no. 1, pp. 26–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-H. Ha, D.-U. Lee, J.-T. Lee et al., “4-Hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 329–333, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Besser, G. Krämer, R. Thümler, J. Bohl, L. Gutmann, and H. C. Hopf, “Acute trimethyltin limbic-cerebellar syndrome,” Neurology, vol. 37, no. 6, pp. 945–950, 1987. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Yang, J. Kim, T. Kim et al., “Possible involvement of galectin-3 in microglial activation in the hippocampus with trimethyltin treatment,” Neurochemistry International, vol. 61, no. 7, pp. 955–962, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Kim, M. Yang, S.-H. Kim et al., “Possible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in mice,” PLoS ONE, vol. 8, no. 8, Article ID e70356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Kim, M. Yang, Y. Son et al., “Glial activation with concurrent up-regulation of inflammatory mediators in trimethyltin-induced neurotoxicity in mice,” Acta Histochemica, vol. 116, no. 8, pp. 1490–1500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Lee, M. Yang, J. Kim et al., “Nestin expression and glial response in the hippocampus of mice after trimethyltin treatment,” Acta Histochemica, vol. 116, no. 8, pp. 1276–1288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Iadecola, “Bright and dark sides of nitric oxide in ischemic brain injury,” Trends in Neurosciences, vol. 20, no. 3, pp. 132–139, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Endres, D. Biniszkiewicz, R. W. Sobol et al., “Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase,” The Journal of Clinical Investigation, vol. 113, no. 12, pp. 1711–1721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. H. J. Kim, I. K. Hwang, and M. H. Won, “Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia,” Brain Research, vol. 1181, no. 1, pp. 130–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. H.-J. Kim, S.-R. Lee, and K.-D. Moon, “Ether fraction of methanol extracts of Gastrodia elata, medicinal herb protects against neuronal cell damage after transient global ischemia in gerbils,” Phytotherapy Research, vol. 17, no. 8, pp. 909–912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Zeng, S. Zhang, L. Zhang, K. Zhang, and X. Zheng, “A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro,” Planta Medica, vol. 72, no. 15, pp. 1359–1365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Bie, Y. Chen, J. Han, H. Dai, H. Wan, and T. Zhao, “Effects of gastrodin on amino acids after cerebral ischemia-reperfusion injury in rat striatum,” Asia Pacific Journal of Clinical Nutrition, vol. 16, no. 1, pp. 305–308, 2007. View at Google Scholar · View at Scopus
  42. X. Xu, Y. Lu, and X. Bie, “Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons,” Planta Medica, vol. 73, no. 7, pp. 650–654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Findeis, “Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization,” Biochimica et Biophysica Acta, vol. 1502, no. 1, pp. 76–84, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. R. B. Postuma, W. He, J. Nunan et al., “Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures,” Journal of Neurochemistry, vol. 74, no. 3, pp. 1122–1130, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. D. S. H. L. Kim, J.-Y. Kim, and Y. S. Han, “Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult,” Journal of Alternative and Complementary Medicine, vol. 13, no. 3, pp. 333–340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Su, Q. Wang, C. Wang, K. Chan, Y. Sun, and H. Kuang, “The treatment of Alzheimer's disease using Chinese Medicinal Plants: from disease models to potential clinical applications,” Journal of Ethnopharmacology, vol. 152, no. 3, pp. 403–423, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. G.-B. Huang, T. Zhao, S. S. Muna et al., “Therapeutic potential of Gastrodia elata blume for the treatment of alzheimer's disease,” Neural Regeneration Research, vol. 8, no. 12, pp. 1061–1070, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. G.-H. Lee, H.-R. Kim, S.-Y. Han et al., “Gastrodia elata blume and its pure compounds protect BV-2 microglial-derived cell lines against β-amyloid: the involvement of GRP78 and CHOP,” Biological Research, vol. 45, no. 4, pp. 403–410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Dauer and S. Przedborski, “Parkinson's disease: mechanisms and models,” Neuron, vol. 39, no. 6, pp. 889–909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. B. R. Bloem, I. Irwin, O. J. S. Buruma et al., “The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease,” Journal of the Neurological Sciences, vol. 97, no. 2-3, pp. 273–293, 1990. View at Publisher · View at Google Scholar · View at Scopus
  51. K. F. Tipton and T. P. Singer, “Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds,” Journal of Neurochemistry, vol. 61, no. 4, pp. 1191–1206, 1993. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Kumar, I.-S. Kim, S. V. More, B.-W. Kim, Y.-Y. Bahk, and D.-K. Choi, “Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 514095, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. H. An, I. S. Kim, S. Koppula et al., “Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells,” Journal of Ethnopharmacology, vol. 130, no. 2, pp. 290–298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Jiang, Y. Hu, L. Liu, J. Cai, C. Peng, and Q. Li, “Gastrodin protects against MPP+-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells,” Neurochemistry International, vol. 75, pp. 79–88, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. I. S. Kim, D.-K. Choi, and H. J. Jung, “Neuroprotective effects of vanillyl alcohol in gastrodia elata blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells,” Molecules, vol. 16, no. 7, pp. 5349–5361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Fabbrini, J. M. Brotchie, F. Grandas, M. Nomoto, and C. G. Goetz, “Levodopa-induced dyskinesias,” Movement Disorders, vol. 22, no. 10, pp. 1379–1389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. S.-J. An, S.-K. Park, I. K. Hwang et al., “Gastrodin decreases immunoreactivities of γ-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils,” Journal of Neuroscience Research, vol. 71, no. 4, pp. 534–543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. J. J. Choi, E.-H. Oh, M. K. Lee, Y. B. Chung, J. T. Hong, and K.-W. Oh, “Gastrodiae Rhizoma ethanol extract enhances pentobarbital-induced sleeping behaviors and rapid eye movement sleep via the activation of GABAA-ergic transmission in rodents,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 426843, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Jiang, H. Wu, Y. Hu, J. Li, and Q. Li, “Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade,” Cellular and Molecular Neurobiology, vol. 34, no. 4, pp. 591–602, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. C.-F. Ng, C.-H. Ko, C.-M. Koon et al., “The aqueous extract of rhizome of Gastrodia elata protected Drosophila and PC12 cells against beta-amyloid-induced neurotoxicity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 516741, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. S. J. Yu, J. R. Kim, C. K. Lee et al., “Gastrodia elata blume and an active component, p-hydroxybenzyl alcohol reduce focal ischemic brain injury through antioxidant related gene expressions,” Biological and Pharmaceutical Bulletin, vol. 28, no. 6, pp. 1016–1020, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Wang, R. Zhang, Y. Qiao et al., “Gastrodin ameliorates depression-like behaviors and up-regulates proliferation of hippocampal-derived neural stem cells in rats: involvement of its anti-inflammatory action,” Behavioural Brain Research, vol. 266, pp. 153–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. J.-N. Dai, Y. Zong, L.-M. Zhong et al., “Gastrodin inhibits expression of inducible no synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways,” PLoS ONE, vol. 6, no. 7, Article ID e21891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Li, X. Chen, N. Zhang, Y. Song, and Y. Mu, “Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats,” Neural Regeneration Research, vol. 7, no. 5, pp. 325–331, 2012. View at Google Scholar · View at Scopus
  65. C.-L. Hsieh, C.-L. Chen, N.-Y. Tang et al., “Gastrodia elata BL mediates the suppression of nNOS and microglia activation to protect against neuronal damage in kainic acid-treated rats,” The American Journal of Chinese Medicine, vol. 33, no. 4, pp. 599–611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. E.-K. Ahn, H.-J. Jeon, E.-J. Lim, H.-J. Jung, and E.-H. Park, “Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 476–482, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. J.-H. Choi and D.-U. Lee, “A new citryl glycoside from Gastrodia elata and its inhibitory activity on GABA transaminase,” Chemical & Pharmaceutical Bulletin, vol. 54, no. 12, pp. 1720–1721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. N.-I. Baek, S. Y. Choi, J. K. Park et al., “Isolation and identification of succinic semialdehyde dehydrogenase inhibitory compound from the rhizome of Gastrodia elata blume,” Archives of Pharmacal Research, vol. 22, no. 2, pp. 219–224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. J. W. Jung, B. H. Yoon, H. R. Oh et al., “Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice,” Biological and Pharmaceutical Bulletin, vol. 29, no. 2, pp. 261–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. H. H. Szeto, “Mitochondria-targeted peptide antioxidants: novel neuroprotective agents,” The AAPS Journal, vol. 8, no. 3, pp. E521–E531, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. R. Pieczenik and J. Neustadt, “Mitochondrial dysfunction and molecular pathways of disease,” Experimental and Molecular Pathology, vol. 83, no. 1, pp. 84–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Liu and J.-S. Hong, “Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention,” The Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Vezzani and T. Granata, “Brain inflammation in epilepsy: experimental and clinical evidence,” Epilepsia, vol. 46, no. 11, pp. 1724–1743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Sierra, O. Abiega, A. Shahraz, and H. Neumann, “Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis,” Frontiers in Cellular Neuroscience, vol. 7, article 6, 2013. View at Publisher · View at Google Scholar · View at Scopus